诺瓦瓦克斯医药(NVAX)盘前暴涨超105% 与赛诺菲安万特(SNY)达成价值数十亿美元的合作协议

金吾资讯05-10

金吾财讯 | 诺瓦瓦克斯医药(NVAX)盘前暴涨，涨幅最高达200%，暂涨105.15%，报9.17美元。消息面上，公司宣布与法国制药巨头赛诺菲达成一项价值数十亿美元的合作协议。根据协议，双方将从明年开始联合商业化诺瓦瓦克斯医药的新冠疫苗，并共同开发针对冠状病毒和流感的组合疫苗。诺瓦瓦克斯首席执行官John Jacobs表示，这项许可协议将有助于公司解除此前发布的“持续经营”警告。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2434853117?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-05-10 20:28","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2434853117","market":"us","top_or_hot":-1,"title":"诺瓦瓦克斯医药(NVAX)盘前暴涨超105% 与赛诺菲安万特(SNY)达成价值数十亿美元的合作协议","media":"金吾资讯","content":"<div>\n<p>金吾财讯 | 诺瓦瓦克斯医药(NVAX)盘前暴涨，涨幅最高达200%，暂涨105.15%，报9.17美元。消息面上，公司宣布与法国制药巨头赛诺菲达成一项价值数十亿美元的合作协议。根据协议，双方将从明年开始联合商业化诺瓦瓦克斯医药的新冠疫苗，并共同开发针对冠状病毒和流感的组合疫苗。诺瓦瓦克斯首席执行官John Jacobs表示，这项许可协议将有助于公司解除此前发布的“持续经营”警告。</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102029148af10bcd&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>诺瓦瓦克斯医药(NVAX)盘前暴涨超105% 与赛诺菲安万特(SNY)达成价值数十亿美元的合作协议</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n诺瓦瓦克斯医药(NVAX)盘前暴涨超105% 与赛诺菲安万特(SNY)达成价值数十亿美元的合作协议\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-10 20:28 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102029148af10bcd&s=b><strong>金吾资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>金吾财讯 | 诺瓦瓦克斯医药(NVAX)盘前暴涨，涨幅最高达200%，暂涨105.15%，报9.17美元。消息面上，公司宣布与法国制药巨头赛诺菲达成一项价值数十亿美元的合作协议。根据协议，双方将从明年开始联合商业化诺瓦瓦克斯医药的新冠疫苗，并共同开发针对冠状病毒和流感的组合疫苗。诺瓦瓦克斯首席执行官John Jacobs表示，这项许可协议将有助于公司解除此前发布的“持续经营”警告。</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102029148af10bcd&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SNY","symbol_name":"赛诺菲安万特","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102029148af10bcd&s=b","article_id":"2434853117","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102029148af10bcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2434853117","pubTimestamp":1715344112,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"金吾财讯 | 诺瓦瓦克斯医药(NVAX)盘前暴涨，涨幅最高达200%，暂涨105.15%，报9.17美元。消息面上，公司宣布与法国制药巨头赛诺菲达成一项价值数十亿美元的合作协议。根据协议，双方将从明年开始联合商业化诺瓦瓦克斯医药的新冠疫苗，并共同开发针对冠状病毒和流感的组合疫苗。诺瓦瓦克斯首席执行官John Jacobs表示，这项许可协议将有助于公司解除此前发布的“持续经营”警告。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"SNY":"赛诺菲安万特","BK4588":"碎股","BK4568":"美国抗疫概念","BK4139":"生物科技","NVAX":"诺瓦瓦克斯医药","BK4585":"ETF&股票定投概念","BK4007":"制药"},"translate_title":"Novavax Pharmaceuticals (NVAX) soared more than 105% before the market and reached a cooperation agreement worth billions of dollars with Sanofi-Aventis (SNY)","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":1,"SNY":1},"content_text":"金吾财讯 | 诺瓦瓦克斯医药(NVAX)盘前暴涨，涨幅最高达200%，暂涨105.15%，报9.17美元。消息面上，公司宣布与法国制药巨头赛诺菲达成一项价值数十亿美元的合作协议。根据协议，双方将从明年开始联合商业化诺瓦瓦克斯医药的新冠疫苗，并共同开发针对冠状病毒和流感的组合疫苗。诺瓦瓦克斯首席执行官John Jacobs表示，这项许可协议将有助于公司解除此前发布的“持续经营”警告。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2434853117"}